Apoptosis-Inducing Activity and Antiproliferative Effect of Gossypin on PC-3 Prostate Cancer Cells
1Department of Pharmacology, Faculty of Medicine, Kastamonu University, Kastamonu, Turkey.
Aim:
The rapid growth, morbidity and mortality of prostate cancer, and the lack of effective treatment have attracted great interest of researchers to find novel cancer therapies aiming at the effect of gossypin on cell proliferation and apoptosis of PC-3 cells.
Methods:
The effect of gossypin on cell viability was determined using MTT assay at 5-100μg/ml and cisplatin (50μM) in a time-dependent manner in PC-3 cell lines. The expression levels of caspase-3 (CASP3) and caspase-9 (CASP9) for apoptosis and Nuclear Factor Kappa B (NFKB1) for survival, inflammation, and growth were evaluated by real-time PCR. Hoechst staining was used to analyze apoptosis.
Results:
Gossypin showed an anti-proliferative effect on PC3 cell line in a time- and dose-dependent manner. In addition, gossypin led to a significant increase in apoptosis genes (CASP3, CASP9) when compared to control while it caused a decrease in the level of NFKB1, which is accepted as apoptosis inhibitor (p<0.05) (cisplatin-like). Gossypin 50 and 100μM significantly induced apoptotic mechanism in PC-3 cells. However, no apoptotic or commonly stained nuclei have been observed in control group cells.
Conclusion:
The results indicated that gossypin can be defined as a promising anticancer agent for PC-3 human prostate cancer cell line.
Insights
Gossypin demonstrates significant anticancer effects against prostate cancer cells by inhibiting proliferation and inducing apoptosis. This natural compound shows promise as a novel therapeutic agent for PC-3 human prostate cancer.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Prostate cancer presents a significant global health challenge due to its high morbidity and mortality rates.
- Current treatments for prostate cancer are limited, necessitating the development of novel therapeutic strategies.
- Gossypin, a natural flavonoid, has garnered interest for its potential anticancer properties.
Purpose of the Study:
- To investigate the effect of gossypin on the proliferation and apoptosis of PC-3 human prostate cancer cells.
- To evaluate gossypin's potential as a novel anticancer agent.
Main Methods:
- PC-3 cells were treated with varying concentrations of gossypin (5-100μg/ml) and cisplatin (50μM) in a time-dependent manner.
- Cell viability was assessed using MTT assay.
- Apoptosis-related gene expression (CASP3, CASP9) and survival/inflammation gene expression (NFKB1) were analyzed via real-time PCR.
- Apoptosis was further analyzed using Hoechst staining.
Main Results:
- Gossypin exhibited a time- and dose-dependent anti-proliferative effect on PC-3 cells.
- Gossypin significantly upregulated the expression of apoptosis-related genes (CASP3, CASP9) and downregulated the expression of the apoptosis inhibitor NFKB1 (p<0.05).
- Concentrations of 50 and 100μM gossypin significantly induced apoptosis in PC-3 cells, similar to cisplatin, with no observed apoptosis in control cells.
Conclusions:
- Gossypin demonstrates significant anticancer activity against the PC-3 human prostate cancer cell line.
- The findings suggest gossypin acts by inhibiting cell proliferation and promoting apoptosis.
- Gossypin is a promising candidate for further development as a novel therapeutic agent for prostate cancer.
More Related Videos
06:48An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
GPCRs Regulate Adenylyl Cylase Activity
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
Apoptosis
